The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir Implant
Open accessAbstract
BACKGROUND: Sustained-release, intraocular implants that deliver ganciclovir are an alternative method for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome (AIDS). METHODS: We conducted a randomized study of 188 patients with AIDS and newly diagnosed cytomegalovirus retinitis. The patients were randomly assigned to treatment with an implant delivering 1 microg of ganciclovir per hour, an implant delivering 2 microg of ganciclovir per hour, or intravenous ganciclovir. The primary outcome we studied was progression of cytomegalovirus retinitis. RESULTS: The median time to progression of retinitis was 221 days with the 1-microg-per-hour implant (75 eyes), 191 days with the 2-microg-per-hour implant (71 eyes), and 71 days with ganciclovir administered intravenously (76 eyes; P<0.001). The risk of progression of retinitis was almost three times as great among patients treated with intravenous ganciclovir as among those treated with a ganciclovir implant (risk ratio, 2.8; P<0.001). However, the risk of disease in the initially uninvolved eye was lower with intravenous ganciclovir than with a ganciclovir implant (risk ratio, 0.5; P=0.19). Patients treated with intravenous ganciclovir were also less likely to have extraocular cytomegalovirus infections (0, vs. 10.3 percent in the two implant groups; P=0.04). CONCLUSIONS: For the treatment of cytomegalovirus retinitis, the sustained-release ganciclovir implant is more effective than intravenous ganciclovir, but patients treated with a ganciclovir implant alone remain at greater risk for the development of cytomegalovirus disease outside of the treated eye.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
New Visual Acuity Charts for Clinical Research
Ferris, F. L., Kassoff, A., Bresnick, G. H., & Bailey, I. (1982) · American Journal of Ophthalmology · doi:10.1016/0002-9394(82)90197-0 · Cited by 2,142
Acquired Immune Deficiency Syndrome
Holland, G. N., Pepose, J. S., Pettit, T. H., Gottlieb, M. S., Yee, R. D., & Foos, R. Y. (1983) · Ophthalmology · doi:10.1016/s0161-6420(83)80009-8 · Cited by 840
Gallant, J. E., Moore, R. D., Richman, D. D., Keruly, J., Chaisson, R. E., & Zidovudine Epidemiology Study Group (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.6.1223 · Cited by 529
(1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260401 · Cited by 487
Collaborative DHPG Treatment Study Group (1986) · New England Journal of Medicine · doi:10.1056/nejm198603273141301 · Cited by 427
Cytomegalovirus Retinitis and Acquired Immunodeficiency Syndrome
Jabs, D. A. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070010077031 · Cited by 379
Lalezari, J. P., Stagg, R. J., Kuppermann, B. D., Holland, G. N., Kramer, F., Ives, D. V., Youle, M., Robinson, M. R., Drew, W. L., & Jaffe, H. S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-4-199702150-00001 · Cited by 372
Self-citationMartin, D. F. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090240037023 · Cited by 338
Self-citationPalestine, A. G., Polis, M. A., De Smet, M. D., Baird, B. F., Falloon, J., Kovacs, J. A., Davey, R. T., Zurlo, J. J., Zunich, K. M., Davis, M., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-665 · Cited by 327
Self-citationSanborn, G. E. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140044023 · Cited by 230
Henry, K., Cantrill, H., Fletcher, C., Chinnock, B. J., & Balfour, H. H. (1987) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)74163-7 · Cited by 196
Treatment of Cytomegalovirus Retinitis with Intravitreal Ganciclovir
Cantrill, H. L., Henry, K., Melroe, N. H., Knobloch, W. H., Ramsay, R. C., & Balfour, H. H. (1989) · Ophthalmology · doi:10.1016/s0161-6420(89)32900-9 · Cited by 185
(1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-4-199702150-00002 · Cited by 178
Longitudinal Study of Cytomegalovirus Retinitis in Acquired Immune Deficiency Syndrome
Gross, J. G., Bozzette, S. A., Mathews, W. C., Spector, S. A., Abramson, I. S., McCutchan, J. A., Mendez, T., Munguia, D., & Freeman, W. R. (1990) · Ophthalmology · doi:10.1016/s0161-6420(90)32552-6 · Cited by 162
Intravitreal Sustained-Release Ganciclovir
Smith, T. J. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140111037 · Cited by 157
Jacobson, M. A., O’Donnell, J. J., & MILLS, J. S. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.5.736 · Cited by 153
Intravitreal Ganciclovir in the Treatment of AIDS-associated Cytomegalovirus Retinitis
Ussery, F. M., Gibson, S. R., Conklin, R. H., Piot, D. F., Stool, E. W., & Conklin, A. J. (1988) · Ophthalmology · doi:10.1016/s0161-6420(88)33147-7 · Cited by 148
Long-term Intravitreal Ganciclovir Therapy for Cytomegalovirus Retinopathy
Heinemann, M. H. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070020849025 · Cited by 147
Toxicity of Combined Ganciclovir and Zidovudine for Cytomegalovirus Disease Associated with AIDS
Höchster, H. S., Dieterich, D. T., Bozzette, S. A., Reichman, R. C., Connor, J. D., Liebes, L., Sonke, R. L., Spector, S. A., Valentine, F. T., Pettinelli, C., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-2-111 · Cited by 130
Spector, S. A., Weingeist, T. A., Pollard, R. B., Dieterich, D. T., Sarno, T., Benson, C. A., Busch, D. F., Freeman, W. R., Montague, P., Kaplan, H. J., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.3.557 · Cited by 129
Foscarnet—Ganciclovir Cytomegalovwus Retinitis Trial
(1994) · Ophthalmology · doi:10.1016/s0161-6420(94)31181-x · Cited by 128
Cited by
Contradicted and Initially Stronger Effects in Highly Cited Clinical Research
Ioannidis, J. P. A. (2005) · JAMA · doi:10.1001/jama.294.2.218 · Cited by 1,465
An overview of clinical and commercial impact of drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 520
Nanotechnology in ocular drug delivery
Sahoo, S. K., Dilnawaz, F., & Krishnakumar, S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.021 · Cited by 510
Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
Martin, D. F., Kuppermann, B. D., Wolitz, R. A., Palestine, A. G., Li, H., & Robinson, C. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904083401402 · Cited by 485
Self-citationAntiviral drugs for cytomegalovirus diseases
Biron, K. K. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.002 · Cited by 468
Metadata
- Authors
- Musch, D. C., Martin, D. F., Gordon, J. F., Davis, M. D., & Kuppermann, B. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1997-07-10
- Volume
- 337
- Issue
- 2
- Pages
- 83-90
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2326455829
- Cited by
- 286
- References
- 26
- FWCI
- 17.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.